azacitidine has been researched along with Carcinoma, Basal Cell, Pigmented in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JH; Ganapathy, V; Kolhe, R; Lokeshwar, BL; Manicassamy, S; Mariappan, G; Pathania, R; Prasad, PD; Ramachandran, S; Sharma, S; Shi, H; Thakur, P; Thangaraju, M | 1 |
1 other study(ies) available for azacitidine and Carcinoma, Basal Cell, Pigmented
Article | Year |
---|---|
Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Carcinoma, Basal Cell; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Drug Therapy, Combination; Female; High-Throughput Nucleotide Sequencing; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2016 |